Fmoc-N-Me-Tyr(tBu)-OH

Fmoc-N-Me-Tyr(tBu)-OH is an Fmoc-protected, N-methylated tyrosine derivative bearing a tert-butyl-protected phenolic side chain, combining a chiral amino acid backbone with orthogonally protected functional groups. The N-methyl amide character reduces the availability of the nitrogen for classical peptide coupling while still supporting controlled incorporation as an N-methylated residue during protected amino acid synthesis. The Fmoc group enables base-labile deprotection for stepwise solid-phase peptide assembly, whereas the tBu ether/phenol protection is acid-labile and compatible with common peptide cleavage conditions. The aromatic phenol functionality, locked as a tBu-protected group, provides a defined handle for later side-chain functionalization after deprotection, making the compound a stereochemically defined intermediate for peptide science and downstream synthetic elaboration.

1. Peptide Synthesis

Fmoc-N-Me-Tyr(tBu)-OH is used in peptide building block preparation for solid-phase and solution-phase peptide synthesis where an N-methylated tyrosine residue is required. The Fmoc carbamate supports base-mediated removal to generate a reactive N-terminus for sequential coupling, while the N-methyl substitution modulates amide hydrogen-bonding patterns in the growing chain. The tyrosine side chain is protected as a tert-butyl-protected phenol, maintaining compatibility with standard coupling and deprotection cycles without premature phenolic reactivity. Incorporation of this protected amino acid derivative can enable the construction of peptide analogs with altered backbone conformation and side-chain presentation for subsequent biochemical evaluation and synthetic diversification.

2. Peptidomimetics

Fmoc-N-Me-Tyr(tBu)-OH is applied in peptidomimetic design where N-methylation and phenolic side-chain protection are leveraged to tune conformational behavior and functional group accessibility. The N-methylated backbone segment can be introduced as a chiral, stereochemically defined unit that participates in amide bond formation while reducing donor capacity for hydrogen bonding interactions. The protected tyrosine phenol preserves the aromatic hydroxyl as a masked handle during scaffold assembly, allowing later conversion to conjugatable motifs or phenol-derived pharmacophore variants after deprotection. Downstream use can include generating libraries of N-methylated peptide analogs and structure-defined mimetics suited for structure-activity relationship studies and molecular recognition investigations.

3. Side-Chain Functionalization

Fmoc-N-Me-Tyr(tBu)-OH supports side-chain functionalization workflows by carrying an orthogonally protected tyrosine phenol that can be revealed after peptide assembly or intermediate synthesis. The tert-butyl-protected phenolic group can be removed under conditions compatible with peptide or protected intermediate handling, exposing a phenolic hydroxyl for subsequent derivatization such as etherification, esterification, or coupling to electrophiles used in bioconjugation chemistry. The Fmoc group provides a controlled N-protection strategy during synthesis, ensuring that phenol reactivity remains suppressed until the desired stage. Resulting derivatives can serve as functionalized amino acid intermediates for generating labeled peptides, affinity reagents, or chemically modified building blocks for applied biochemical research.

4. Chemical Biology

Fmoc-N-Me-Tyr(tBu)-OH is suitable for chemical biology research that requires incorporation of N-methylated tyrosine into peptide probes and recognition elements. The combination of a protected aromatic phenol and an Fmoc-controlled amino terminus enables reliable assembly of defined peptide sequences while maintaining side-chain masking during probe synthesis. The N-methyl residue can be used to influence backbone rigidity and local polarity, which may affect binding-site engagement and probe stability in chemical labeling contexts. Downstream formation of functionalized peptide probes can be used to support studies of molecular recognition, target engagement mapping, and reagent generation for biochemical investigations where controlled functional group presentation is required.

5. Pharmaceutical Manufacturing

Fmoc-N-Me-Tyr(tBu)-OH is relevant to pharmaceutical manufacturing and fine chemical production routes that rely on protected amino acid chemistry for generating peptide intermediates and N-methylated residues. The Fmoc protection strategy aligns with industrially established peptide synthesis workflows, enabling reproducible deprotection and coupling steps during intermediate preparation. The orthogonal protection of the tyrosine phenol as a tert-butyl group helps manage chemoselectivity during manufacturing-scale synthesis by preventing unwanted phenolic side reactions under coupling conditions. Resulting N-methylated, tyrosine-containing protected intermediates can be carried forward into downstream peptide assembly, purification, and final deprotection steps used to produce well-defined peptide-based materials and research-grade manufacturing intermediates.

6. Analytical Research

Fmoc-N-Me-Tyr(tBu)-OH can be employed in analytical research as a stereochemically defined reference material for method development involving amino acid derivatives and peptide fragments. The presence of Fmoc and tert-butyl-protected groups provides characteristic chemical signatures for chromatographic and spectrometric characterization of protected amino acid building blocks and their deprotected forms. The N-methylated tyrosine structure supports targeted monitoring of coupling efficiency and identity confirmation for peptide synthesis workflows that incorporate N-methyl residues. Downstream analytical use can include calibrating detection methods for protected amino acids, verifying intermediate composition during peptide construction, and supporting impurity profiling in amino acid derivative manufacturing and research synthesis.

1. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

2. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore

3. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

4. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L

5. Implications of ligand-receptor binding kinetics on GLP-1R signalling